Skip to content
Sunday, November 15, 2026
CornerTrackLab

Zimbabwe Turns Down ‘Unbalanced’ American Healthcare Assistance Agreement Due to Data Apprehensions

Health funding illustration
The offered US funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a major US health deal worth $367m (272 million pounds) over five years due to Washington's insistence on confidential information.

The decision was revealed following a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesperson later stated that the US was seeking biological samples for research and commercial gain but was unwilling to share the resulting advantages from future treatments.

"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for further negotiations to secure a agreement suitable to all parties so the nation's vital HIV treatment initiative can continue.

Broader Context

This development comes after a similar situation in Kenya, where a high court suspended a similar health funding agreement after concerns were raised about the security of Kenyans' health data.

After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the American government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and accountability.

According to statements, 16 African countries have to date agreed to similar agreements, constituting over $18.3bn in committed funds.

Details of the Rejected Deal

This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this collaboration might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador said.

However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.

"In essence, our country would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be accessible to our people should a future health crisis emerge."

Sovereignty and International Frameworks

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were upending systems previously established via the global health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.

"This system is designed to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

These objections over the US deal "are not meant as anti-American sentiment," he added.

"We are open to continued discussions with our US partners on how future co-operation could be arranged in a manner that respects the independence and dignity of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that talks need to persist since a large portion of the nation's HIV programmes depended on international support.

"In cases where technical issues arise, including those involving information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it commented.

The halted deal emphasises the complex challenges between accepting crucial international aid and protecting national sovereignty in an increasingly data-driven world.

SG
About the author

Sharon Golden

Elena Voss is a technologist and writer exploring the intersection of creativity and digital innovation.

CornerTrackLab

Type to search articles.